DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Comparing computational times for simulations when using PBPK model template and stand-alone implementations of PBPK models

Journal Article · · Frontiers in Toxicology

Introduction We previously developed a PBPK model template that consists of a single model “superstructure” with equations and logic found in many physiologically based pharmacokinetic (PBPK) models. Using the template, one can implement PBPK models with different combinations of structures and features. Methods To identify factors that influence computational time required for PBPK model simulations, we conducted timing experiments using various implementations of PBPK models for dichloromethane and chloroform, including template and stand-alone implementations, and simulating four different exposure scenarios. For each experiment, we measured the required computational time and evaluated the impacts of including various model features (e.g., number of output variables calculated) and incorporating various design choices (e.g., different methods for estimating blood concentrations). Results We observed that model implementations that treat body weight and dependent quantities as constant (fixed) parameters can result in a 30% time savings compared with options that treat body weight and dependent quantities as time-varying. We also observed that decreasing the number of state variables by 36% in our PBPK model template led to a decrease of 20–35% in computational time. Other factors, such as the number of output variables, the method for implementing conditional statements, and the method for estimating blood concentrations, did not have large impacts on simulation time. In general, simulations with PBPK model template implementations of models required more time than simulations with stand-alone implementations, but the flexibility and (human) time savings in preparing and reviewing a model implemented using the PBPK model template may justify the increases in computational time requirements. Conclusion Our findings concerning how PBPK model design and implementation decisions impact computational speed can benefit anyone seeking to develop, improve, or apply a PBPK model, with or without the PBPK model template.

Sponsoring Organization:
USDOE
OSTI ID:
2520222
Journal Information:
Frontiers in Toxicology, Journal Name: Frontiers in Toxicology Vol. 7; ISSN 2673-3080
Publisher:
Frontiers Media SACopyright Statement
Country of Publication:
Switzerland
Language:
English

References (17)

Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers journal April 2022
Model reduction in mathematical pharmacology journal March 2018
Population pharmacokinetic reanalysis of a Diazepam PBPK model: a comparison of Stan and GNU MCSim journal April 2019
Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseases journal August 2021
Assessing interindividual variability by Bayesian-PBPK modeling journal January 2016
Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery journal April 2022
Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene journal December 2019
GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models journal March 2009
Markov Chain Monte Carlo: an introduction for epidemiologists journal April 2013
A Model Template Approach for Rapid Evaluation and Application of Physiologically Based Pharmacokinetic Models for Use in Human Health Risk Assessments: A Case Study on Per- and Polyfluoroalkyl Substances journal June 2021
A model template approach for rapid evaluation and application of physiologically based pharmacokinetic models: extension to volatile organic compounds journal March 2023
Physiologically Based Pharmacokinetic Model Use in Risk Assessment—Why Being Published Is Not Enough journal November 2011
Application of an Updated Physiologically Based Pharmacokinetic Model for Chloroform to Evaluate CYP2E1-Mediated Renal Toxicity in Rats and Mice journal November 2012
Framework for Evaluation of Physiologically‐Based Pharmacokinetic Models for Use in Safety or Risk Assessment journal December 2004
Physiologically Based Pharmacokinetic (PBPK) Modeling of Interstrain Variability in Trichloroethylene Metabolism in the Mouse journal May 2014
Solving Differential Equations in R : Package deSolve journal January 2010
Computational estimation of errors generated by lumping of physiologically-based pharmacokinetic (PBPK) interaction models of inhaled complex chemical mixtures journal December 2011